Abrdn Healthcare Investors (HQH) Revenue History
Annual and quarterly revenue from 2014 to present
HQH Revenue Over Time (2014–2024)
HQH Revenue Growth History
9 of 10 years with positive growth- FY2014 revenue growth
- N/A
- FY2015 revenue growth
- +102.0%
- FY2016 revenue growth
- +10.8%
- FY2017 revenue growth
- +17.0%
- FY2018 revenue growth
- +20.7%
- FY2019 revenue growth
- +12.0%
- FY2020 revenue growth
- +17.5%
- FY2021 revenue growth
- -27.5%
- FY2022 revenue growth
- +27.6%
- FY2023 revenue growth
- +24.4%
- FY2024 revenue growth
- +4.6%
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $5.5M | — |
| Q2 2024 | $5.3M | — |
| Q4 2023 | $4.7M | — |
| Q2 2023 | $5.6M | — |
| Q4 2022 | $4.3M | — |
| Q2 2022 | $4.0M | — |
| Q4 2021 | $3.2M | — |
| Q2 2021 | $3.3M | — |
HQH Revenue Analysis (2014–2024)
Current Revenue & Growth
As of July 8, 2026, Abrdn Healthcare Investors (HQH) generated trailing twelve-month (TTM) revenue of $21.1 million, reflecting strong growth of +17.2% year-over-year. The most recent quarter (Q4 2024) recorded $5.5 million in revenue, up 3.0% sequentially.
Historical Growth Trajectory
HQH's 5-year compound annual growth rate (CAGR) stands at +7.2%, indicating steady revenue expansion. The 3-year CAGR of +18.4% exceeds the 5-year average, indicating an acceleration in the most recent period. Abrdn Healthcare Investors's highest annual revenue of $10.8 million was recorded in 2024, an all-time high.
Peer Comparison
Compared to Financial Services sector peers — including HQL, HQI (-11.8% YoY), and FHI — HQH has outperformed the peer group in revenue growth. Compare HQH vs HQL →
HQH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HQHCurrent | $21M | +17.2% | +7.2% | -2.0% | |
 HQL | $86M | - | - | 99.1% | |
 HQI | $31M | -11.8% | +17.3% | 26.7% | |
 FHI | $1.8B | - | - | 29.5% | |
 AMGN | $36.7B | +9.1% | +7.6% | 29.1% | |
 GILD | $29.4B | +3.5% | +3.6% | 39.7% |
HQH Historical Revenue Data (2014–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $10.8M | - | $10.8M | 100.0% | $-220,271 | -2.0% |
| 2023 | $10.3M | - | $10.3M | 100.0% | $-1,185,481 | -11.5% |
| 2022 | $8.3M | - | $8.3M | 100.0% | $-3,670,183 | -44.4% |
| 2021 | $6.5M | - | $6.5M | 100.0% | $-6,230,384 | -96.1% |
| 2020 | $8.9M | - | $8.9M | 100.0% | $-1,971,715 | -22.1% |
| 2019 | $7.6M | - | $7.6M | 100.0% | $-2,871,917 | -37.8% |
| 2018 | $6.8M | - | $6.8M | 100.0% | $-4,120,803 | -60.7% |
| 2017 | $5.6M | - | $5.6M | 100.0% | $-5,164,404 | -91.9% |
| 2016 | $4.8M | - | $4.8M | 100.0% | $-6,283,079 | -130.9% |
| 2015 | $4.3M | - | $4.3M | 100.0% | $-7,850,794 | -181.2% |
| 2014 | $2.1M | - | $2.1M | 100.0% | $-7,157,179 | -333.8% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HQH — Frequently Asked Questions
Quick answers to the most common questions about buying HQH stock.
Is HQH's revenue growth accelerating or slowing?
HQH revenue growth is accelerating. TTM revenue reached $21M, up +17.2% year-over-year — ahead of the 5-year CAGR of +7.2%. This indicates the business is expanding faster than its historical baseline.
What is HQH's revenue history from 2014 to 2026?
Abrdn Healthcare Investors (HQH) revenue history spans 2014 to 2026. TTM revenue as of 2026 is $21M, growing at +17.2% YoY. The 5-year CAGR is +7.2%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is HQH's long-term revenue growth rate (CAGR)?
Abrdn Healthcare Investors's 5-year revenue CAGR of +7.2% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +17.2% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for HQH.
Why does HQH's quarterly revenue fluctuate?
HQH quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Abrdn Healthcare Investors's revenue data from 2014 to 2026 shows full historical quarterly detail on this page.
How is HQH's revenue distributed by segment?
HQH reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does HQH's revenue compare to industry peers?
Abrdn Healthcare Investors (HQH) with TTM revenue of $21M and +17.2% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.